U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.1840C>G (p.Arg614Gly) AND RYR1-Related Disorders

Germline classification:
Likely pathogenic (1 submission)
Last evaluated:
Mar 23, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000655520.7

Allele description [Variation Report for NM_000540.3(RYR1):c.1840C>G (p.Arg614Gly)]

NM_000540.3(RYR1):c.1840C>G (p.Arg614Gly)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.1840C>G (p.Arg614Gly)
HGVS:
  • NC_000019.10:g.38457545C>G
  • NG_008866.1:g.28846C>G
  • NM_000540.3:c.1840C>GMANE SELECT
  • NM_001042723.2:c.1840C>G
  • NP_000531.2:p.Arg614Gly
  • NP_000531.2:p.Arg614Gly
  • NP_001036188.1:p.Arg614Gly
  • LRG_766t1:c.1840C>G
  • LRG_766:g.28846C>G
  • LRG_766p1:p.Arg614Gly
  • NC_000019.9:g.38948185C>G
  • NM_000540.2:c.1840C>G
Protein change:
R614G
Links:
dbSNP: rs118192172
NCBI 1000 Genomes Browser:
rs118192172
Molecular consequence:
  • NM_000540.3:c.1840C>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.1840C>G - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
RYR1-Related Disorders
Identifiers:
MedGen: CN239331

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000777451Invitae
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Likely pathogenic
(Mar 23, 2023)
germlineclinical testing

PubMed (7)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermia.

Gillard EF, Otsu K, Fujii J, Khanna VK, de Leon S, Derdemezi J, Britt BA, Duff CL, Worton RG, MacLennan DH.

Genomics. 1991 Nov;11(3):751-5.

PubMed [citation]
PMID:
1774074

Comparison of the segregation of the RYR1 C1840T mutation with segregation of the caffeine/halothane contracture test results for malignant hyperthermia susceptibility in a large Manitoba Mennonite family.

Serfas KD, Bose D, Patel L, Wrogemann K, Phillips MS, MacLennan DH, Greenberg CR.

Anesthesiology. 1996 Feb;84(2):322-9.

PubMed [citation]
PMID:
8602662
See all PubMed Citations (7)

Details of each submission

From Invitae, SCV000777451.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (7)

Description

This variant is not present in population databases (gnomAD no frequency). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Arg614 amino acid residue in RYR1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 1774074, 8602662, 10352931, 11493496, 11668625, 12411788). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RYR1 protein function. ClinVar contains an entry for this variant (Variation ID: 544395). This missense change has been observed in individual(s) with autosomal dominant malignant hyperthermia susceptibility (Invitae). This sequence change replaces arginine, which is basic and polar, with glycine, which is neutral and non-polar, at codon 614 of the RYR1 protein (p.Arg614Gly).

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Feb 20, 2024